SANDOZ GRUP SAGLIK URUNLERI ILACLAR

Type: Manufacturer

Introduction:

SANDOZ GRUP SAGLIK URUNLERI ILACLAR is the Turkish subsidiary of Sandoz, a global leader in generic pharmaceuticals and biosimilars. As an independent division of the Novartis Group, Sandoz specializes in developing, manufacturing, and marketing high-quality, affordable generic medicines and biosimilar products worldwide. The Turkish entity operates as a key part of this global manufacturing and supply chain, focusing on the production, distribution, and commercialization of a wide range of pharmaceutical products for the Turkish market and beyond. It contributes significantly to healthcare access by providing essential medications across various therapeutic areas.

SANDOZ GRUP SAGLIK URUNLERI ILACLAR in Turkey produces or markets a range of pharmaceutical products, including:

* **Generic Medicines:** A wide variety of generic drugs across various therapeutic areas.

* **Biosimilars:** Biosimilar versions of biologic medicines.

* **Anti-Infectives:** Antibiotics and other medications to treat infections.

* **Cardiovascular Medicines:** Drugs for treating heart conditions and related issues.

* **Central Nervous System Medicines:** Medications for neurological and psychiatric disorders.

* **Pain Management:** Analgesics and other pain relief products.

* **Gastrointestinal Medicines:** Treatments for digestive system disorders.

* **Oncology Medicines:** Products used in the treatment of cancer.

* **Respiratory Medicines:** Medications for respiratory conditions like asthma and COPD.

Please note that this is not an exhaustive list, and the specific products available may vary.